Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection

Faloppi, 2014, The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management, BMC Cancer, 14, 110, 10.1186/1471-2407-14-110 Poon, 2009, Management of hepatocellular carcinoma in Asia: consensus statement from the Asian oncology summit, Lancet Oncol., 10, 1111, 10.1016/S1470-2045(09)70241-4 Villanueva, 2010, New strategies in hepatocellular carcinoma: genomic prognostic markers, Clin. Cancer Res., 16, 4688, 10.1158/1078-0432.CCR-09-1811 Lopez, 1996, The value of liver function tests in hepatocellular carcinoma, Malays. J. Pathol., 18, 95 Xu, 1992, Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study, Am. J. Gastroenterol., 87, 991 Hann, 2012, Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients, PLoS One, 7, e47687, 10.1371/journal.pone.0047687 Carr, 2016, Hepatocellular carcinoma extrahepatic metastasis in relation to tumor size and alkaline phosphatase levels, Oncology, 90, 136, 10.1159/000443480 Carr, 2013, Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase, Oncology, 85, 153, 10.1159/000354416 Xu, 2014, Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis, World J. Gastroenterol., 20, 10944, 10.3748/wjg.v20.i31.10944 Yu, 2011, Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?, J. Gastrointest. Surg., 1440, 10.1007/s11605-011-1537-3 Ma, 2014, γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma, Ann. Surg. Oncol., 3084, 10.1245/s10434-014-3724-4 Fu, 2016, Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy, Tumour Biol., 37, 3433, 10.1007/s13277-015-4136-1 Scartozzi, 2012, The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management, PLoS One, 7, e32653, 10.1371/journal.pone.0032653 Zhang, 2015, Lactate dehydrogenase is an important prognostic indicator for hepatocellular carcinoma after partial hepatectomy, Transl. Oncol., 497, 10.1016/j.tranon.2015.11.006 Zhang, 2011, Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization, Eur. J. Gastroenterol. Hepatol., 23, 787, 10.1097/MEG.0b013e32834902dd Guiu, 2012, Serum gamma-glutamyl-transferase independently predicts outcome after transarterial chemoembolization of hepatocellular carcinoma: external validation, Cardiovasc Interv. Radiol., 35, 1102, 10.1007/s00270-011-0293-9 Leung, 2002, Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients, Cancer, 94, 1760, 10.1002/cncr.10384 Yamamoto, 2003, Nuclear localization of alkaline phosphatase in cultured human cancer cells, Med. Electron Microsc., 47, 10.1007/s007950300006 Hanigan, 1999, Altered expression of gamma-glutamyl transpeptidase in human tumors, Hum. Pathol., 30, 300, 10.1016/S0046-8177(99)90009-6 Corti, 2010, Gammaglutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting, Anticancer Res., 30, 1169 Toyokuni, 1995, Persistent oxidative stress in cancer, FEBS Lett., 358, 1, 10.1016/0014-5793(94)01368-B Daubeuf, 2001, Differential regulation of gammaglutamyltransferase mRNAs in four human tumour cell lines, Biochim. Biophys. Acta, 1568, 67, 10.1016/S0304-4165(01)00201-X Bouman, 2002, Gammaglutamyl transpeptidase expression in Ewing's sarcoma cells: up-regulation by interferons, Biochem. J., 364, 719, 10.1042/bj20011854 Semenza, 2000, HIF-1: mediator of physiological and pathophysiological responses to hypoxia, J. Appl. Physiol., 88, 1474, 10.1152/jappl.2000.88.4.1474 Zha, 2011, Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis, Cancer Res., 71, 13, 10.1158/0008-5472.CAN-10-1668